Dyslipidaemias

13 registered clinical trials studyying Dyslipidaemias — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery NCT07064135	Barmherzige Brüder Linz	N/A
Completed	A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multip NCT01218204	GlaxoSmithKline	Phase 2
Completed	Study to Test GSK256073 in Patients With Dyslipidemia NCT00903617	GlaxoSmithKline	Phase 2
Completed	A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Sa NCT00783549	GlaxoSmithKline	Phase 1
Completed	Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects NCT00808093	GlaxoSmithKline	Phase 1
Completed	A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers NCT00608699	GlaxoSmithKline	Phase 1
Completed	A Second Study to Determine the Effect of GSK256073A on HVTs NCT00551694	GlaxoSmithKline	Phase 1
Completed	Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipi NCT00474864	GlaxoSmithKline	Phase 2
Completed	Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy Volunteers NCT00488449	GlaxoSmithKline	Phase 1
Terminated	Effect Of GW501516X On How The Heart Obtains And Uses Energy NCT00318617	GlaxoSmithKline	—
Completed	An Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And Inflammation NCT00388180	GlaxoSmithKline	—
Completed	GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol NCT00158899	GlaxoSmithKline	Phase 2
Completed	Dyslipidemia Study Investigating The Increase In "Good Cholesterol" NCT00169559	GlaxoSmithKline	Phase 2